<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Serum alpha–actinin antibody status in systemic lupus erythematosus and its potential in the diagnosis of lupus nephritis</title>
	<subject_fa>Internal</subject_fa>
	<subject>Internal</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;margin-top: 0cm; margin-right: 0cm; margin-bottom: 0pt;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue; font-size: 10pt;&quot;&gt;Background: &lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt;&quot;&gt;&lt;font color=&quot;#000000&quot;&gt;In lupus nephritis (LN), deposition of pathogenic autoantibodies in the glomeruli is mediated via cross-reactivity with alpha-actinin. Association of serum alpha-actinin antibody (A&amp;alpha;A) with LN has been shown in a few studies but the results are controversial.&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-indent: 0cm; margin-top: 0cm; margin-right: 0cm; margin-bottom: 0pt;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue; font-size: 10pt;&quot;&gt;Methods:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt;&quot;&gt;&lt;font color=&quot;#000000&quot;&gt; Eighty patients into entered the study. The diagnosis of SLE was confirmed according to the American College of Rheumatology criteria and LN was diagnosed by proteinuria &amp;ge; 500 mg/24 hour and kidney biopsy. Serum A&amp;alpha;A was measured with ELISA method. Receiver operating characteristics curve (ROC) analysis was applied to determine an optimal cutoff value for A&amp;alpha;A to discriminate patients with and without LN at the highest sensitivity and specificity. The association of A&amp;alpha;A with LN was determined by logistic regression analysis with calculation of odds ratio (OR).&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-indent: 0cm; margin-top: 0cm; margin-right: 0cm; margin-bottom: 0pt;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue; font-size: 10pt;&quot;&gt;Results:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt;&quot;&gt;&lt;font color=&quot;#000000&quot;&gt; Serum A&amp;alpha;A was significantly lower in LN as compared with SLE patients without LN (P=0.001). Serum A&amp;alpha;A at cutoff levels &amp;le; 59.5 pg/ml discriminated the two groups with sensitivity, specificity, positive predictive values of 60%. 90% and 85.7%, respectively. Serum A&amp;alpha;A level &amp;le; 59.5 pg/ml was significantly associated with LN (OR=13.5, P=0.001) and the OR increased to 25.2 (P=0.003) after adjustment for age, sex, C3, C4, anti-ds-DNA, SLEDAI.&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p style=&quot;text-indent: 0cm; margin-top: 0cm; margin-right: 0cm; margin-bottom: 0pt;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue; font-size: 10pt;&quot;&gt;Conclusion: &lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt;&quot;&gt;&lt;font color=&quot;#000000&quot;&gt;This study indicates that serum A&amp;alpha;A decreases in LN and serum level &amp;le; 59.5 pg/ml is SLE and is predictive of nephritis.&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Systemic lupus erythematous, Nephritis, Anti-alpha-actinicn antibody, Diagnosis</keyword>
	<start_page>272</start_page>
	<end_page>277</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-564-1&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mansour</first_name>
	<middle_name></middle_name>
	<last_name>Babaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>babaeim47@yahoo.com</email>
	<code>10031947532846006626</code>
	<orcid>10031947532846006626</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Rheumatology, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Rezaieyazdi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rezaieyazdi-z@mums.ac.ir.</email>
	<code>10031947532846006627</code>
	<orcid>10031947532846006627</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Rheumatic Disease Research Center,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nayereh</first_name>
	<middle_name></middle_name>
	<last_name>Saadati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Saadatin@mums.ac.ir</email>
	<code>10031947532846006628</code>
	<orcid>10031947532846006628</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Rheumatic Disease Research Center,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Massoud</first_name>
	<middle_name></middle_name>
	<last_name>Saghafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>saghafim@mums.ac.ir</email>
	<code>10031947532846006629</code>
	<orcid>10031947532846006629</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Rheumatic Disease Research Center,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Sahebari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sahebarim@mums.ac.ir</email>
	<code>10031947532846006630</code>
	<orcid>10031947532846006630</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Rheumatic Disease Research Center,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Bahram</first_name>
	<middle_name></middle_name>
	<last_name>Naghibzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>naghibzadehb@mums.ac.ir</email>
	<code>10031947532846006631</code>
	<orcid>10031947532846006631</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Rheumatic Disease Research Center,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Habibollah</first_name>
	<middle_name></middle_name>
	<last_name>Esmaily</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>esmailyh@mums.ac.ir</email>
	<code>10031947532846006632</code>
	<orcid>10031947532846006632</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Center for Health Sciences Research, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
